The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.
Open accessAbstract
Psoriatic skin is characterized by microvascular hyperpermeability and angioproliferation, but the mechanisms responsible are unknown. We report here that the hyperplastic epidermis of psoriatic skin expresses strikingly increased amounts of vascular permeability factor (VPF; vascular endothelial growth factor), a selective endothelial cell mitogen that enhances microvascular permeability. Moreover, two VPF receptors, kdr and flt-1, are overexpressed by papillary dermal microvascular endothelial cells. Transforming growth factor alpha (TGF-alpha), a cytokine that is also overexpressed in psoriatic epidermis, induced VPF gene expression by cultured epidermal keratinocytes. VPF secreted by TGF-alpha-stimulated keratinocytes was bioactive, as demonstrated by its mitogenic effect on dermal microvascular endothelial cells in vitro. Together, these findings suggest that TGF-alpha regulates VPF expression in psoriasis by an autocrine mechanism, leading to vascular hyperpermeability and angiogenesis. Similar mechanisms may operate in tumors and in healing skin wounds which also commonly express both VPF and TGF-alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., & Berger, W. H. (1987) · PubMed · Cited by 898
Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., & Senger, D. R. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.211 · Cited by 898
Self-citationBrown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., & van de Water, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1375 · Cited by 878
Self-citationVascular permeability factor (VPF, VEGF) in tumor biology
Senger, D. R., Van De Water, L., Brown, L. F., Nagy, J. A., Yeo, K.-T., Yeo, T.-K., Berse, B., Jackman, R. W., Dvorak, A. M., & Dvorak, H. F. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665960 · Cited by 840
Self-citationTransforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor
Schreiber, A. B., Winkler, M. E., & Derynck, R. (1986) · Science · doi:10.1126/science.2422759 · Cited by 838
Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line
Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., & Chambon, P. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.24.7895 · Cited by 728
Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor
Marquardt, H., Hunkapiller, M. W., Hood, L. E., & Todaro, G. J. (1984) · Science · doi:10.1126/science.6320373 · Cited by 666
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Self-citationBrown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., & Dvorak, H. F. (1993) · PubMed · Cited by 635
Self-citationBrown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., & Senger, D. R. (1993) · PubMed · Cited by 564
Self-citationGospodarowicz, D., Abraham, J. A., & Schilling, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7311 · Cited by 559
Overexpression of Transforming Growth Factor α in Psoriatic Epidermis
Elder, J. T., Fisher, G. J., Lindquist, P. B., Bennett, G. L., Pittelkow, M. R., Coffey, R. J., Ellingsworth, L., Derynck, R., & Voorhees, J. J. (1989) · Science · doi:10.1126/science.2916128 · Cited by 527
Dvorak, H. F., Sioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Van de Water, L., & Senger, D. R. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1275 · Cited by 483
Self-citationMassagué, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43959-7 · Cited by 473
Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., & Oldfield, E. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116165 · Cited by 461
Claffey, K. P., Wilkison, W. O., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42003-0 · Cited by 357
Self-citationAltered [125I] Epidermal Growth Factor Binding and Receptor Distribution in Psoriasis
Nanney, L. B., Stoscheck, C. M., Magid, M., & King, L. E. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285389 · Cited by 285
The Primary Histologic Lesion of Seborrheic Dermatitis and Psoriasis*
Pinkus, H., & Mehregan, A. H. (1966) · Journal of Investigative Dermatology · doi:10.1038/jid.1966.16 · Cited by 267
Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., & Giovinco, P. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.1.166 · Cited by 230
Self-citationGottlieb, A. B., Chang, C. K., Posnett, D. N., Fanelli, B., & Tam, J. P. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.670 · Cited by 223
Yeo, K. T., Wang, H. H., Nagy, J. A., Sioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, E., Senger, D. R., & Dvorak, H. F. (1993) · PubMed · Cited by 194
Self-citationCell Kinetic Basis for Pathophysiology of Psoriasis
Weinstein, G. D., McCullough, J. L., & Ross, P. A. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12283594 · Cited by 173
Human keratinocytes are a major source of cutaneous platelet-derived growth factor.
Ansel, J. C., Tiesman, J. P., Olerud, J. E., Krueger, J. G., Krane, J. F., Tara, D., Shipley, G. D., Gilbertson, D. M., Usui, M. L., & Hart, C. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116636 · Cited by 157
Fry, L. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb03248.x · Cited by 145
Mast cells and macrophages in early relapsing psoriasis
Schubert, C., & Christophers, E. (1985) · Archives of Dermatological Research · doi:10.1007/bf00509232 · Cited by 140
Detmar, M. J., Tenorio, S., Hettmannsperger, U., Ruszczak, Z., & Orfanos, C. E. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12555746 · Cited by 118
Self-citationDetmar, M. J., & Orfanos, C. E. (1990) · Archives of Dermatological Research · doi:10.1007/bf00371643 · Cited by 72
Self-citationSioussat, T. M., Dvorak, H. F., Brock, T. A., & Senger, D. R. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1109 · Cited by 58
Self-citationKrane, J. F., Murphy, D. P., Gottlieb, A. B., Carter, D. M., Hart, C. E., & Krueger, J. G. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12476485 · Cited by 56
Effects of Azelaic Acid on Proliferation and Ultrastructure of Mouse Keratinocytes in Vitro
Detmar, M. J., Mayer‐da‐Silva, A., Stadler, R., & Orfanos, C. E. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12277353 · Cited by 55
Self-citationBraverman, I. M., & Keh-Yen, A. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12355222 · Cited by 42
Schmid, P., Cox, D., McMaster, G. K., & Itin, P. H. (1993) · Archives of Dermatological Research · doi:10.1007/bf00371833 · Cited by 31
Cited by
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Metadata
- Authors
- Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., & Dvorak, H. F.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-09-01
- Volume
- 180
- Issue
- 3
- Pages
- 1141-1146
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2150732175
- Cited by
- 685
- References
- 38
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.